ExamFinch.com My Study

Study guide

7.4 High-Alert Medications: Anticoagulants

Practice this exam

NCLEX-RN Registered Nurse

Track your progress as you read

Finished sections get a check mark.

1 Introduction

About the NCLEX-RN Exam Next Generation NCLEX (NGN) Clinical Judgment Measurement Model (NCJMM) How to Use This Course

2 Chapter 2: Management of Care

2.1 Legal Rights and Responsibilities 2.2 Advance Directives and Self-Determination 2.3 Informed Consent Protocols 2.4 Client Advocacy and Rights (HIPAA) 2.5 Assignment, Delegation, and Supervision 2.6 Five Rights of Delegation 2.7 Scope of Practice (RN vs LPN vs UAP) 2.8 Ethical Practice Principles

3 Chapter 3: Safety and Infection Prevention and Control

3.1 Standard Precautions and Hand Hygiene 3.2 Transmission-Based Precautions (Contact, Droplet, Airborne) 3.3 PPE Donning and Doffing Sequences 3.4 Fall Prevention and Restraints 3.5 Fire Safety (RACE/PASS) 3.6 Disaster Triage and Emergency Response

4 Chapter 4: Health Promotion and Maintenance

4.1 Growth and Development (Erikson/Piaget) 4.2 Developmental Stages: Infancy through Older Adult 4.3 Maternal and Newborn Care (Antepartum) 4.4 Intrapartum Care and Fetal Monitoring 4.5 Postpartum Care (BUBBLE-HE) 4.6 Health Screening Guidelines 4.7 Immunization Schedules

5 Chapter 5: Psychosocial Integrity

5.1 Therapeutic Communication Techniques 5.2 Non-Therapeutic Communication (What to Avoid) 5.3 Anxiety Disorders and Mental Health Concepts 5.4 Schizophrenia: Hallucinations and Delusions 5.5 Depression and Suicide Assessment 5.6 Substance Misuse and Withdrawal 5.7 Grief and End-of-Life Care

6 Chapter 6: Basic Care and Comfort

6.1 Mobility and Hazards of Immobility 6.2 Assistive Devices (Crutches, Canes, Walkers) 6.3 Nutrition and Diet Therapy 6.4 Enteral Nutrition (Tube Feeding) 6.5 Bowel Elimination and Ostomy Care 6.6 Urinary Elimination and Catheter Care

7 Chapter 7: Pharmacological and Parenteral Therapies

7.1 Medication Administration Rights 7.2 Medication Calculations 7.3 High-Alert Medications: Insulins 7.4 High-Alert Medications: Anticoagulants 7.5 High-Alert Medications: Opioids 7.6 High-Alert Medications: Digoxin and Electrolytes 7.7 IV Therapy and Complications 7.8 Blood Product Administration 7.9 Total Parenteral Nutrition (TPN)

8 Chapter 8: Reduction of Risk Potential

8.1 Laboratory Values: Hematology (CBC) 8.2 Laboratory Values: Metabolic Panel (BMP) 8.3 Laboratory Values: Coagulation Studies 8.4 Vital Signs and Trend Recognition 8.5 Perioperative Care (Pre-Op and Post-Op) 8.6 Nasogastric Tubes and Therapeutic Procedures

9 Chapter 9: Physiological Adaptation

9.1 Fluid Imbalances (Hypovolemia and Hypervolemia) 9.2 Arterial Blood Gases (ABGs) and Acid-Base Balance 9.3 Medical Emergencies: Stroke (CVA) 9.4 Medical Emergencies: Myocardial Infarction (MONA) 9.5 Diabetic Emergencies (Hypoglycemia and DKA) 9.6 Respiratory Conditions (COPD, Pneumonia) 9.7 Cardiac Conditions (Heart Failure) 9.8 Neurological Conditions (Seizures)

7.4 High-Alert Medications: Anticoagulants

Key Takeaways Explain This Topic AI

Heparin therapy is monitored with aPTT - therapeutic range is 1.5-2.5 times normal (approximately 60-80 seconds)

Warfarin (Coumadin) is monitored with PT/INR - therapeutic range is INR 2.0-3.0 for most indications

Antidote for Heparin is Protamine Sulfate; antidote for Warfarin is Vitamin K (Phytonadione)

Never give anticoagulants IM - increases risk of hematoma; SubQ or IV only

  • Hold heparin if aPTT > 100 seconds; hold warfarin if INR > 4.0 and notify provider
  • Last updated: January 2026

Anticoagulants are among the most dangerous medications when errors occur. Understanding the different agents, monitoring parameters, and management of complications is essential for safe nursing practice.

Anticoagulant Classes

  • Class Mechanism Route Monitoring
  • Unfractionated Heparin Inhibits thrombin and factor Xa IV, SubQ aPTT
  • Low Molecular Weight Heparin Primarily inhibits factor Xa SubQ only Anti-Xa levels (if needed)
  • Warfarin Blocks vitamin K-dependent factors Oral PT/INR
  • Direct Oral Anticoagulants (DOACs) Direct thrombin or Xa inhibitors Oral Usually none required
  • Unfractionated Heparin (UFH)

Administration:

  • IV: Bolus followed by continuous infusion
  • SubQ: Prophylactic dosing for DVT prevention
  • NEVER IM (hematoma risk)

Monitoring:

  • Parameter Normal Therapeutic
  • aPTT 25-35 seconds 60-80 seconds (1.5-2.5× normal)

When to Hold:

  • aPTT > 100 seconds
  • Signs of active bleeding
  • Before invasive procedures
  • Antidote: Protamine Sulfate
  • 1 mg Protamine reverses approximately 100 units of Heparin
  • Give slowly IV (rapid administration causes hypotension)
  • Caution in patients with fish allergies
  • Low Molecular Weight Heparin (LMWH)

Common Agents:

  • Enoxaparin (Lovenox)
  • Dalteparin (Fragmin)

Advantages over UFH:

  • Predictable response - routine monitoring not required
  • Once or twice daily SubQ dosing
  • Can be given at home

Administration:

  • SubQ into abdominal fat
  • Do NOT expel air bubble
  • Do NOT rub injection site
  • Rotate sites

When to Monitor Anti-Xa Levels:

  • Renal impairment
  • Obesity
  • Pregnancy
  • Very low body weight
  • Partial Reversal: Protamine (only 60% effective for LMWH)
  • Warfarin (Coumadin)
  • Mechanism: Blocks vitamin K-dependent clotting factors (II, VII, IX, X)

Monitoring:

  • Parameter Normal Therapeutic (most conditions)
  • PT 12-15 seconds Prolonged
  • INR 0.8-1.1 2.0-3.0

Higher INR Target (2.5-3.5):

  • Mechanical heart valves
  • Recurrent thromboembolism

When to Hold:

  • INR > 4.0 - hold and notify provider
  • Active bleeding - hold and reverse
  • Before surgery - typically held 5 days pre-op
  • Antidote: Vitamin K (Phytonadione)
  • Oral or IV (IV given slowly - anaphylaxis risk)
  • Effect takes 12-24 hours
  • For immediate reversal: Fresh Frozen Plasma (FFP) or Prothrombin Complex Concentrate (PCC)
  • Warfarin Drug and Food Interactions
  • Category Effect on INR Examples
  • Vitamin K foods ↓ INR Leafy greens, broccoli, liver
  • CYP450 inhibitors ↑ INR Azole antifungals, macrolides
  • CYP450 inducers ↓ INR Rifampin, phenytoin, carbamazepine
  • Salicylates/NSAIDs ↑ Bleeding risk Aspirin, ibuprofen

Patient Teaching:

  • Maintain consistent vitamin K intake (don't eliminate, just keep constant)
  • Report unusual bleeding or bruising
  • Wear medical alert identification
  • Inform all healthcare providers
  • Direct Oral Anticoagulants (DOACs)
  • Drug Target Dosing Reversal Agent
  • Dabigatran (Pradaxa) Thrombin BID Idarucizumab (Praxbind)
  • Rivaroxaban (Xarelto) Factor Xa Daily with food Andexanet alfa
  • Apixaban (Eliquis) Factor Xa BID Andexanet alfa
  • Edoxaban (Savaysa) Factor Xa Daily Andexanet alfa

Advantages:

  • Fixed dosing without routine monitoring
  • Fewer drug-food interactions than warfarin
  • Rapid onset (no bridge therapy needed)

Disadvantages:

  • Renal dosing required
  • Specific reversal agents expensive/limited
  • Not for mechanical heart valves
  • Signs of Bleeding Complications
  • Type Signs to Monitor
  • GI bleeding Melena (black tarry stool), hematemesis, hematochezia
  • Intracranial Sudden headache, confusion, neurologic changes
  • Genitourinary Hematuria (blood in urine)
  • Skin Petechiae, ecchymoses, hematoma
  • Other Bleeding gums, prolonged bleeding from cuts, epistaxis
  • Nursing Interventions for Bleeding
  • Hold the anticoagulant - Do not give next dose
  • Apply direct pressure - To accessible bleeding sites
  • Notify provider immediately
  • Administer reversal agent as ordered
  • Monitor vital signs - Hypotension indicates significant blood loss
  • Type and screen/crossmatch - Prepare for possible transfusion
  • Document thoroughly
  • Lab Monitoring Quick Reference
  • Drug Lab Test Therapeutic Range
  • Heparin aPTT 60-80 sec (1.5-2.5× normal)
  • Warfarin PT/INR INR 2.0-3.0
  • LMWH Anti-Xa 0.5-1.0 units/mL
  • On the Exam
  • Know which lab monitors which drug
  • Recognize therapeutic vs. supratherapeutic ranges
  • Match antidotes to anticoagulants
  • Identify contraindications to anticoagulation